Frovocimab
CAS: 1643672-70-1
Ref. TM-T77014
| 1mg | 279.00 € | ||
| 5mg | 675.00 € | ||
| 10mg | 921.00 € | ||
| 25mg | 1,391.00 € | ||
| 50mg | 1,839.00 € | ||
| 100mg | 2,511.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Product Information
Name:
Frovocimab
Synonyms:
- LY3015014
- LY 3015014
Description:
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody targeting PCSK9 that binds to the catalytic domain of PCSK9.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T77014 Frovocimab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
